Colitis: Difference between revisions
Ochuko Ajari (talk | contribs) |
Ochuko Ajari (talk | contribs) |
||
Line 211: | Line 211: | ||
*[[Cilansetron]] | *[[Cilansetron]] | ||
*[[Clindamycin]] | *[[Clindamycin]] | ||
*[[Clostridium difficile]] | *[[Clostridium difficile]] <ref name="pmid25073304">{{cite journal| author=Gié O, Clerc D, Giulieri S, Demartines N| title=[Clostridial colitis: diagnosis and strategies for management]. | journal=Rev Med Suisse | year= 2014 | volume= 10 | issue= 434 | pages= 1309-13 | pmid=25073304 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25073304 }} </ref> | ||
*[[Co-amoxiclav]] | *[[Co-amoxiclav]] | ||
*[[Colitis ulcerosa]] | *[[Colitis ulcerosa]] |
Revision as of 01:55, 23 March 2015
WikiDoc Resources for Colitis |
Articles |
---|
Most recent articles on Colitis |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Colitis at Clinical Trials.gov Clinical Trials on Colitis at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Colitis
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Directions to Hospitals Treating Colitis Risk calculators and risk factors for Colitis
|
Healthcare Provider Resources |
Causes & Risk Factors for Colitis |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: M.Umer Tariq [2]; Maham Khan [3]; Ogheneochuko Ajari, MB.BS, MS [4]; Rim Halaby, M.D. [5]
Synonyms and keywords: autoimmune colitis, ulcerative colitis, Crohn's colitis, infectious colitis, pseudomembranous colitis, enterohemorrhagic colitis, microscopic colitis, lymphocytic colitis, collagenous colitis, diversion colitis, chemical colitis, ischemic colitis, indeterminate colitis, atypical colitis, fulminant colitis, immune mediated colitis, immune colitis
Overview
Colitis is the inflammation of the colon, that can be either acute or chronic.
Classification
Classes of Colitis | Disorders |
Autoimmune colitis | |
Infectious colitis |
|
Microscopic colitis | |
Iatrogenic | |
Vacular disease | |
Unclassifiable |
|
Notes:
- Fulminant colitis is any colitis with a rapid downhill clinical course; in addition to the diarrhea, fever, and anemia seen in colitis, the patient has severe abdominal pain and presents a clinical picture similar to that of septicemia, where shock is present.
- Irritable bowel syndrome, a separate disease, has been called spastic colitis or spastic colon. This name causes confusion, since colitis is not a feature of irritable bowel syndrome.
- Immune mediated colitis is the experimental name in animal studies of ulcerative colitis. It is a synonym of ulcerative colitis, but it should not be used as a synonym when referring to ulcerative colitis.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Common Causes
- Crohn's disease
- Inflammatory bowel disease
- Ischemic colitis
- Pseudomembranous colitis
- Ulcerative colitis
Causes by Organ System
Causes in Alphabetical Order
Diagnosis
Symptoms
Physical Examination
Diagnostic Tests
Colitis is associated with the following findings:
- Swelling of the colon tissue
- Bleeding
- Erythema (redness) of the surface of the colon
- Ulcerations of the colon
Common tests which reveal these signs include:
- X-rays of the colon
- Testing the stool for blood and pus
- Sigmoidoscopy
- Colonoscopy
Additional tests include stool cultures and blood tests, including blood chemistry tests. A high erythrocyte sedimentation rate (ESR) is one typical finding in acute exacerbations of colitis.
Treatment
Medical Therapy
Treatment of colitis may include the administration of antibiotics and general anti-inflammatory medications such as Mesalamine or its derivatives, steroids, or one of a number of other drugs that ameliorate inflammation.
Changes in diet can be effective at treating the symptoms of colitis and easing the side effects. These can include reducing the intake of carbohydrates, lactose products, soft drinks, and caffeine. This approach has been championed by Elaine Gottschall.
Hygienic and naturopathic doctors have taken the diet approach further, attributing bowel inflammation to toxemia stemming from high-protein, fatty diets and other dietary irritants. Changing to a low-fat, minimally-processed, whole-foods diet per the Natural Hygiene self-healing system has been effective in eliminating symptoms and rebuilding health. Dr. Zarin Azar, MD,, is one advocate of this healing system.
Infliximab (or REMICADE) - a drug originally produced to treat Rheumatoid Arthritis - has recently been approved for the treatment of Colitis where traditional treatments have failed. REMICADE is a biologic therapy that recognizes, attaches to, and blocks the action of a protein in your body called tumor necrosis factor alpha (TNF-alpha). TNF-alpha is made by certain blood cells in your body. It is administered through a series of infusions.
Surgery
Approximately half of patients with fulminant colitis require surgery. Surgery usually entails removing the colon and bowel and creating a "pouch" with portions of the small intestine.
References
- ↑ Mohan P, Ramakrishnan MK, Revathy S, Jayanthi V (2011). "Granulomatous colitis in oculocutaneous albinism". Dig Liver Dis. 43 (1): e1. doi:10.1016/j.dld.2009.09.006. PMID 19833565.
- ↑ Gié O, Clerc D, Giulieri S, Demartines N (2014). "[Clostridial colitis: diagnosis and strategies for management]". Rev Med Suisse. 10 (434): 1309–13. PMID 25073304.